Thu07162020

Robins Global News & Noticias



COVID-19 Map Tracker | COVID-19 News Features


  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Consumer Daily Reports

Consumer News: COVID-19 drug remdesivir may cost over $3,000 per treatment

Photo
Photo (c) digicomphoto - Getty Images
Gilead Sciences has disclosed what it plans to charge for its experimental antiviral drug remdesivir, which has gained emergency federal authorization for use to treat the coronavirus (COVID-19).

As with nearly all drug prices, it’s not a simple formula. The drugmaker will charge hospitals more than it charges the government. 

A Wall Street Journal analysis shows the typical hospital patient with commercial insurance would be charged $3,120 for an average course of treatment, but what the consumer ends up paying would depend on their health benefits coverage.

The government would pay the lowest price for people covered by Medicare and Medicaid. The cost would be $390 per dose, which works out to $2.340 for the shortest treatment period. For cases that take longer to treat, the total cost could be $4.290.

Hospital patients receiving the shortest course of remdesivir would be charged $520 per dose, or $3,120 for the shortest treatment course. The cost could total more than $5,000 for cases requiring a longer treatment period.

Possible pushback

The drug company could face some serious pushback from consumer groups and some members of Congress. Late last month, Peter Maybarduk, director of Public Citizen’s Access to Medicines Program, made the argument that Gilead relied on help and funding from the U.S. government to develop remdesivir.

“Gilead did not make this drug alone,” he said. “Public funding was indispensable, and government scientists led the early drug discovery team. It appears the public owns its stake.”

Maybarduk said the government has an obligation to ensure that remdesivir is priced affordably and does not stretch health care budgets during the pandemic.

Measuring the value to health care systems

Gilead Sciences CEO Daniel O’Day told The Journal that the drug is priced below the value it will bring to health care systems, noting it reduces a hospital’s cost of treating COVID-19 patients.

Remdesivir is currently being used in hospitals, on an experimental basis, to treat seriously ill patients. It is also still in the clinical trial process, with Food and Drug Administration (FDA) approval still pending. In early June, the company announced results from a Phase 3 clinical trial that showed promising results on patients with a moderate form of COVID-19.

The company said the study demonstrated that patients in a five-day remdesivir treatment group were 65 percent more likely to have clinical improvement at Day 11 compared with those who were not receiving the drug.



Posted: 2020-06-29 12:52:10

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






YouTube Consumer News Playlists

Consumer Video: 2020 Tesla Model Y First Impressions | Talking Cars with Consumer Reports #263


Related Videos On: 2020 Tesla Model Y First Impressions | Talking Cars with Consumer Reports #263

Published: 13th Jul 2020 03:43:32   By: Consumer Reports

Consumer Video: 2021 Toyota RAV4 Prime First Impressions; Ford's Unveiling of the 2021 F-150 | Talking Cars #262


Related Videos On: 2021 Toyota RAV4 Prime First Impressions; Ford's Unveiling of the 2021 F-150 | Talking Cars #262

Published: 3rd Jul 2020 04:00:12   By: Consumer Reports

Consumer Video: Mini Projector Tips for a Backyard Movie Night | Consumer Reports


Related Videos On: Mini Projector Tips for a Backyard Movie Night | Consumer Reports

Published: 2nd Jul 2020 09:44:41   By: Consumer Reports

Consumer Video: How to Stain a Wood Deck | Consumer Reports


Related Videos On: How to Stain a Wood Deck | Consumer Reports

Published: 2nd Jul 2020 02:03:21   By: Consumer Reports

Consumer Video: 2020 Audi Q3 Test Results; Ford's All-new (Handsfree) Active Drive Assist System | Talking Cars #261


Related Videos On: 2020 Audi Q3 Test Results; Ford's All-new (Handsfree) Active Drive Assist System | Talking Cars #261

Published: 26th Jun 2020 09:00:15   By: Consumer Reports

Car Video: Cheap Sedan Road Trip - 1,000 miles of fear - Big Sedan Challenge - Long Term #5 | Everyday Driver


Related Videos On: Cheap Sedan Road Trip - 1,000 miles of fear - Big Sedan Challenge - Long Term #5 | Everyday Driver

Published: 9th Jul 2020 07:59:50   By: EverydayDriver

Car Video: Fixing the BMW 4-series - BeaverTeef - Paul Designs | Everyday Driver


Related Videos On: Fixing the BMW 4-series - BeaverTeef - Paul Designs | Everyday Driver

Published: 2nd Jul 2020 08:00:27   By: EverydayDriver

Car Video: King of the Hot Hatch - Civic Type-R vs Focus RS - TV Season 3 Ep. 3 | Everyday Driver


Related Videos On: King of the Hot Hatch - Civic Type-R vs Focus RS - TV Season 3 Ep. 3 | Everyday Driver

Published: 27th Jun 2020 04:00:11   By: EverydayDriver

Car Video: Canyon Running - How Tos and Headspace | Everyday Driver


Related Videos On: Canyon Running - How Tos and Headspace | Everyday Driver

Published: 25th Jun 2020 08:18:09   By: EverydayDriver

Car Video: Subaru Ascent - Cupholders on Clearance - Fast Blast | Everyday Driver


Related Videos On: Subaru Ascent - Cupholders on Clearance - Fast Blast | Everyday Driver

Published: 18th Jun 2020 07:50:36   By: EverydayDriver

Product Review Video: I let Insta360's AI edit my skate video


Related Videos On: I let Insta360's AI edit my skate video

Published: 16th Jul 2020 12:00:11   By: CNET

Product Review Video: Peacock app walkthrough and first impressions


Related Videos On: Peacock app walkthrough and first impressions

Published: 16th Jul 2020 03:00:18   By: CNET

Product Review Video: Nintendo Switch 2: What we want to see


Related Videos On: Nintendo Switch 2: What we want to see

Published: 15th Jul 2020 05:00:04   By: CNET

Product Review Video: The Origami King might be the best Paper Mario game yet


Related Videos On: The Origami King might be the best Paper Mario game yet

Published: 15th Jul 2020 01:00:10   By: CNET

Product Review Video: TikTok trouble: Why the US may try to ban the app


Related Videos On: TikTok trouble: Why the US may try to ban the app

Published: 15th Jul 2020 01:00:57   By: CNET

FTC Video: FTC Hearing: Emerging Competition, Innovation, and Market Structure - Nov. 14, 2018 - Session 2


Related Videos On: FTC Hearing: Emerging Competition, Innovation, and Market Structure - Nov. 14, 2018 - Session 2

Published: 13th Jul 2020 04:40:54   By: FTCvideos

FTC Video: FTC Hearing: Economics of Online Advertising; Competition and Consumer...- Nov. 7, 2018 - Session 3


Related Videos On: FTC Hearing: Economics of Online Advertising; Competition and Consumer...- Nov. 7, 2018 - Session 3

Published: 10th Jul 2020 08:25:27   By: FTCvideos

FTC Video: FTC Hearing: Remedies for Competition Problems in Data Markets - Nov. 7, 2018 - Session 2


Related Videos On: FTC Hearing: Remedies for Competition Problems in Data Markets - Nov. 7, 2018 - Session 2

Published: 10th Jul 2020 06:19:04   By: FTCvideos

FTC Video: FTC Hearing: Antitrust Analysis of Data - November 7, 2018 - Session 1


Related Videos On: FTC Hearing: Antitrust Analysis of Data - November 7, 2018 - Session 1

Published: 10th Jul 2020 05:03:27   By: FTCvideos

FTC Video: FTC Hearing: Presentations from Competition and Consumer Protection in... -Nov. 6, 2018 - Session 4


Related Videos On: FTC Hearing: Presentations from Competition and Consumer Protection in... -Nov. 6, 2018 - Session 4

Published: 7th Jul 2020 08:44:55   By: FTCvideos

DIY Video: Ricotta Malt Cheesecake | FOOD | Great Home Ideas


Related Videos On: Ricotta Malt Cheesecake | FOOD | Great Home Ideas

Published: 16th Jul 2020 12:30:08   By: Great Home Ideas

DIY Video: Plant Collector | GARDEN | Great Home Ideas


Related Videos On: Plant Collector | GARDEN | Great Home Ideas

Published: 14th Jul 2020 12:30:03   By: Great Home Ideas

DIY Video: Hand Crafted Wooden Horses| INDOOR | Great Home Ideas


Related Videos On: Hand Crafted Wooden Horses| INDOOR | Great Home Ideas

Published: 12th Jul 2020 12:30:01   By: Great Home Ideas

DIY Video: Honey Cake | FOOD | Great Home Ideas


Related Videos On: Honey Cake | FOOD | Great Home Ideas

Published: 11th Jul 2020 12:30:01   By: Great Home Ideas

DIY Video: Pork and Potato Fritters | FOOD | Great Home Ideas


Related Videos On: Pork and Potato Fritters | FOOD | Great Home Ideas

Published: 10th Jul 2020 12:30:04   By: Great Home Ideas

Business Video: Morgan Stanley Posts Record Profit on Second-Quarter Trading Boom


Related Videos On: Morgan Stanley Posts Record Profit on Second-Quarter Trading Boom

Published: 16th Jul 2020 12:13:06   By: Bloomberg Markets and Finance

Business Video: Carson Block Warns Tesla Short Sellers: ‘I Wouldn’t Do That’


Related Videos On: Carson Block Warns Tesla Short Sellers: ‘I Wouldn’t Do That’

Published: 16th Jul 2020 10:48:02   By: Bloomberg Markets and Finance

Business Video: EU Bourse Access Is Extremely Important, Says SIX CEO


Related Videos On: EU Bourse Access Is Extremely Important, Says SIX CEO

Published: 16th Jul 2020 09:07:15   By: Bloomberg Markets and Finance

Business Video: BlackRock’s Li Upgrades View on European Equities


Related Videos On: BlackRock’s Li Upgrades View on European Equities

Published: 16th Jul 2020 07:08:20   By: Bloomberg Markets and Finance

Business Video: China Returns to Growth; Not Out of the Woods Yet, BofA Says


Related Videos On: China Returns to Growth; Not Out of the Woods Yet, BofA Says

Published: 16th Jul 2020 03:29:32   By: Bloomberg Markets and Finance



Related News Stories From The Web And More

Related Bing News Search Results

Consumer News: COVID-19 drug remdesivir may cost over $3,000 per treatment | Consumer Daily Reports | RobinsPost News Network - Newscast

Gilead rushes to meet Remdesivir demand as virus pressures grow

Tue, 14 Jul 2020 07:00:00 GMT

The local arm of the pharma giant behind a major coronavirus treatment candidate says it is focused on Australia's pandemic preparedness.

Gilead's Remdesivir Data Shows Improved Clinical Recovery, Reduced Death Rate

Fri, 10 Jul 2020 14:21:00 GMT

The data was presented at the Virtual COVID19 Conference as part of the 23rd International AIDS Conference. Remdesivir has received FDA's Emergency Use Authorization for the treatment of ...

HHS allocates Gilead's COVID-19 drug remdesivir to four hardest hit states

Fri, 10 Jul 2020 14:01:00 GMT

(Reuters) - The U.S. government has allocated more than 11,000 courses of Gilead Sciences Inc's COVID-19 treatment remdesivir to the four states now being hardest hit by the fast-spreading outbreak in ...

COVID-19: Gilead's Remdesivir linked to 62% reduction in mortality risk

Fri, 10 Jul 2020 07:14:00 GMT

The comparative analysis released Friday showed the death rate for patients treated with remdesivir was 7.6 per cent at Day 14 compared with 12.5 per cent among patients not taking remdesivir. The ...

Gilead’s Remdesivir Linked to 62% Reduction in Mortality Risk

Fri, 10 Jul 2020 06:36:00 GMT

Gilead Sciences Inc.’s remdesivir reduced mortality risk for Covid-19 patients by 62% compared to standard care, according to a new analysis of trial data released by the drugmaker.

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.